1192801-11-8

Basic information

• Product Name: (3R,5R)-3-[1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethylamino]-5-(3-trifluoromethoxy-phenyl)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one
• Synonyms: (3R,5R)-3-[1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethylamino]-5-(3-trifluoromethoxy-phenyl)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one
• CAS NO: 1192801-11-8
• Molecular Weight: 592.464
• Mol File: 1192801-11-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3R,5R)-3-[1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethylamino]-5-(3-trifluoromethoxy-phenyl)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,5R)-3-[1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethylamino]-5-(3-trifluoromethoxy-phenyl)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one(1192801-11-8)
• EPA Substance Registry System: (3R,5R)-3-[1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethylamino]-5-(3-trifluoromethoxy-phenyl)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one(1192801-11-8)

Safety Data

• Hazardous Substances Data: 1192801-11-8(Hazardous Substances Data)

Upstream product

• 52771-21-8 3-(trifluoromethoxy)benzaldehyde 
• 1192801-23-2 N-[1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethyl]-acetamide 
• 1192801-22-1 2-(2-trifluoromethyl-pyrimidin-4-yl)-propan-2-ol 
• 1192801-24-3 1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethylamine 
• 1031721-47-7 (+/-)-5-(3-trifluoromethoxy-phenyl)-1-(4-trifluoromethyl-phenyl)-3-(4-trifluoromethyl-phenylamino)-1,5-dihydro-pyrrol-2-one 
• 1031721-42-2 (R)-1-(4-trifluoromethylphenyl)-3-[(1R)-1-(4-chlorophenyl)-ethylamino]-5-(3-trifluoromethoxyphenyl)-1,5-dihydropyrrol-2-one 
• 878745-51-8 methyl 2-(trifluoromethyl)pyrimidine-4-carboxylate 
• 1192801-29-8 (R)-3-[1-methyl-1-(2-trifluoromethyl-pyrimidin-4-yl)-ethylamino]-1-(4-trifluoromethyl-phenyl)-5-(3-trifluoromethoxy-phenyl)-1,5-dihydro-pyrrol-2-one 

Relevant articles and documents

1,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS

CB-1 receptor inverse agonist compounds of Formula (I) and pharmaceutical compositions for the treatment of obesity or cognitive impairment associated with schizophrenia.